SPPI Spectrum Pharmaceuticals, Inc.

2.900.03 (+1.05%)
IEX real time price: 12:24:30 PM

Quote

Previous Close
-
Day Range
-
52 Week Range
$2.48-$12.15
Volume
848,968
Avg Volume
2,259,764
Dividend TTM
-
Ex-Dividend Date
-

Valuation

Market Cap
$301.76M
Enterprise Value (EV)
$94.65M
PE Ratio
-
EV/EBITDA
-0.92
Price/Sales
2.73
Price/Book
1.05
PEG Ratio
-

Financials

Revenue
$109.33M
Gross Profit
$54.48M
EBITDA
-$102.77M
EPS, ttm
-$1.13
Profit Margin
-
Revenue/Employee
$465.25K
Next Earnings Date
3/4/2020 (13 days)
Debt to Equity
-
Debt
-
Cash
$203.99M
Net Debt
-

Performance

Beta
1.72
200 Day Moving Avg
$7.27
50 Day Moving Avg
$4.60
52 Week Change
-75.30%
YTD Change
-15.77%
1 Month Change
-5.90%
3 Month Change
-66.97%
6 Month Change
-64.74%
1 Year Change
-75.30%
2 Year Change
-85.86%
5 Year Change
-62.53%

Share Count

Shares Outstanding
104.1M
Float
98.2M
Restricted Shares
5.9M
Restricted Shares, %
5.63%

Spectrum Pharmaceuticals, Inc. Company Details

Sector: Health Technology

Industry: Biotechnology

CEO: Joseph W. Turgeon

Website: http://www.sppirx.com

Description: Spectrum Pharmaceuticals, Inc. is a biotechnology company, which engages in the acquisition, development, and commercialization of pipeline of late-stage clinical and commercial products. It operates through the following brands: FOLOTYN, ZEVALIN, MARQIBO, BELEODAQ, and EVOMELA. The company was founded in December 1987 and is headquartered in Henderson, NV.

Employees: 235

Latest News